Casdin Capital, LLC - 15 Aug 2025 SCHEDULE 13D/A Report for BioLife Solutions, Inc. Common Stock, par value $0.001 per share (BLFS)

Filing Manager
Casdin Capital, LLC
Reporting Manager
Casdin Capital, LLC
Security
BioLife Solutions, Inc. Common Stock, par value $0.001 per share
Symbol
BLFS
Shares outstanding
47,908,321 shares
Disclosed Ownership
6,707,165 shares
Ownership
14%
Form type
SCHEDULE 13D/A
Filing time
21 Aug 2025, 21:35:50 UTC
Date of event
15 Aug 2025
Previous filing
13 Aug 2025
Next filing
17 Oct 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Casdin Capital, LLC disclosed 14% ownership in BioLife Solutions, Inc. Common Stock, par value $0.001 per share (BLFS) on 15 Aug 2025."

Quick Takeaways

  • Casdin Capital, LLC filed SCHEDULE 13D/A for BioLife Solutions, Inc. Common Stock, par value $0.001 per share (BLFS).
  • Disclosed ownership: 14%.
  • Date of event: 15 Aug 2025.

What Changed

  • Previous schedule filing date: 13 Aug 2025.
  • Current filing was accepted on 21 Aug 2025, 21:35.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Casdin Capital, LLC 14% 6,707,165 0 6,707,165 By: /s/ Eli Casdin* Eli Casdin, Managing Member 0001534261
Casdin Partners Master Fund, L.P. 14% 6,707,165 0 6,707,165 By: /s/ Eli Casdin* Eli Casdin, Managing Member of its General Partner 0001534265
Casdin Partners GP, LLC 14% 6,707,165 0 6,707,165 By: /s/ Eli Casdin* Eli Casdin, Managing Member 0001534260
Eli Casdin 14% 6,707,165 0 6,707,165 By: /s/ Eli Casdin* Eli Casdin 0001534264

Sponsored